Search form
Search
contact us
Navigation
home
boards
Jobs
job ratings
cp wire
medtech news
pharmagather
catering
advertise
whistleblower info
pharmaceutical fraud
medical device | DME fraud
clinical lab fraud
False Claims Act
Legal Help
login/register
You are here
Home
»
companies
» chronic myeloid leukemia
chronic myeloid leukemia
Cancer drug biotech Enliven shifts to reverse to move forward as a public company
MedCity News
Sun, 10/16/22 - 05:13 pm
Enliven Therapeutics
Imara
cancer
chronic myeloid leukemia
ASCO: Novartis eyes full nod for Gleevec follow-on Scemblix thanks to new leukemia data
Fierce Pharma
Fri, 05/27/22 - 10:21 am
ASCO 2022
Novartis
Gleevec
Scemblix
CML
chronic myeloid leukemia
Novartis’ ABL001 meets primary endpoint of phase 3 chronic myeloid leukemia study
Pharmaceutical Business Review
Thu, 08/27/20 - 11:01 am
Novartis
asciminib
ABL001
clinical trials
chronic myeloid leukemia
Xspray Pharma reports positive clinical data for HyNap-Dasa product candidate
Pharmaceutical Business Review
Mon, 09/10/18 - 09:30 am
Xspray Pharma
clinical trials
HyNap-Dasa
CML
chronic myeloid leukemia
Pfizer's blood cancer drug Bosulif effective in untreated patients
Yahoo/Reuters
Mon, 12/5/16 - 10:06 am
Pfizer
Bosulif
chronic myeloid leukemia
CML
Ariad's Iclusig Gets FDA OK and Label Update
Investopedia
Wed, 11/30/16 - 10:36 pm
Ariad Pharma
Iclusig
FDA
chronic myeloid leukemia
Ph+ ALL
FDA OKs first generic for Gleevec leukemia pill
Yahoo/AP
Fri, 12/4/15 - 08:25 pm
FDA
Gleevec
generics
Novartis
chronic myeloid leukemia
Sun Pharma
Tasigna Wins Over Gleevec in Ph+CML Patients
Drug Discovery and Development
Tue, 12/9/14 - 11:42 am
Tasigna
Gleevec
chronic myeloid leukemia
Novartis
Glivec Generics May Be Delayed In The U.S. - Buy Novartis
Seeking Alpha
Mon, 12/2/13 - 04:58 pm
Glivec
generics
Novartis
chronic myeloid leukemia
Ariad Declines After Stopping Iclusig Study on Clot Risk
Bloomberg
Sat, 10/19/13 - 03:43 pm
Ariad Pharmaceuticals
Iclusig
chronic myeloid leukemia
leukemia
Does This Orphan Leukemia Treatment Have Blockbuster Potential?
Motley Fool
Thu, 09/12/13 - 10:02 am
Iclusig
Ariad Pharmaceuticals
chronic myeloid leukemia
ARIAD reaches 50% enrollment in Phase 3 EPIC trial
The Fly on the Wall
Wed, 09/4/13 - 09:31 am
Ariad Pharmaceuticals
clinical trials
chronic myeloid leukemia
Iclusig
Ariad Pharma: Three Hurdles For Long-Term Win
The Street
Wed, 07/31/13 - 09:09 am
Ariad Pharmaceuticals
Iclusig
chronic myeloid leukemia
acute lymphoblastic leukemia
leukemia
Ariad Pharma skids as analyst says leukemia pill Iclusig may struggle against older drugs
Yahoo/AP
Wed, 07/17/13 - 10:57 am
Ariad Pharmaceuticals
Iclusig
chronic myeloid leukemia
Ariad's Cancer Drug Iclusig Extends The Gleevec Magic
Seeking Alpha
Wed, 05/22/13 - 04:42 pm
Gleevec
Ariad Pharmaceuticals
Iclusig
CML
Novartis
chronic myeloid leukemia
2 Biotech Companies With Strong Product Launches To Monitor
Seeking Alpha
Tue, 05/14/13 - 05:29 pm
Uceris
Santarus
ulcerative colitis
Iclusig
Ariad Pharmaceuticals
CML
chronic myeloid leukemia
Does Ariad's Leukemia Drug Have Hidden Potential?
Motley Fool
Wed, 05/8/13 - 09:11 am
Ariad Pharmaceuticals
Iclusig
chronic myeloid leukemia
CML
Ariad's Potential Blockbuster Set for EU Debut
Motley Fool
Sat, 03/23/13 - 08:54 am
Ariad
Iclusig
chronic myeloid leukemia
3 Drug Launches You Need to Know in 2013
Motley Fool
Wed, 01/16/13 - 11:18 am
NPS Pharmaceuticals
Gattex
short bowel syndrome
Iclusig
Ariad
chronic myeloid leukemia
Pfizer
Eliquis
Bristol-Myers Squibb
10 Drugs Approved by the FDA in 2012 to Be Thankful For
Motley Fool
Sat, 12/15/12 - 01:28 pm
Xtandi
Medivation
prostate cancer
Stribild
Gilead Sciences
HIV
Belviq
Arena Pharmaceuticals
obesity
weight loss
Qsymia
Vivus
Kyprolis
ONYX Pharmaceuticals
Multiple Myeloma
Omontys
Affymax
anemia
Linzess
irritable bowel syndrome
Ironwood Pharmaceuticals
Bosulif
chronic myeloid leukemia
Pfizer
Amyvid
Alzheimer's disease
Eli Lilly
Eylea
macular degeneration
Regeneron
Pages
1
2
next ›
last »